Health Care • Medical/Dental Instruments
$284.50 ▼ -8.80
(-3.00%)
MKT CAP: $2.27B • VOL: 85.4K
52W L $174 52W H $339
CONSENSUS RATING DISTRIBUTION (40 DESKS)
BUY: 30 HOLD: 8
SELL: 2
12M STREET TARGET RANGE
IMPLIED: +14.0%
LOW
$239
MEDIAN
$319
MEAN
$324
HIGH
$387
STREET BS CREDIBILITY SCORE 1Y BACKTESTED
68/100
EMPIRICAL HIT RATE VS SPOT
GRADES WHETHER SELL-SIDE TARGET REVISIONS LEAD OR CHASE UFPT TAPE
UFPT // FIRM-BY-FIRM ANALYST BACKTEST & BS DETECTOR (ANR <GO>)
CURRENT 90D STREET CONSENSUS
| INSTITUTION / ANALYST | ACTION | RATING | TARGET | PRIOR PT | CALL DATE | PX AT CALL | RET SINCE CALL | 1Y ACCURACY | BS GRADE |
|---|---|---|---|---|---|---|---|---|---|
| Morgan Stanley Institutional Equity Desk | REITERATE | OUTPERFORM | $344.25 | $327.17 | 2025-02-14 | $258.89 | +9.9% | 78% | A |
| Goldman Sachs Global Research Sector Coverage | TARGET REV | STRONG BUY | $358.47 | $335.71 | 2025-02-06 | $267.43 | +6.4% | 74% | A |
| J.P. Morgan Securities US Large Cap | REITERATE | BUY | $324.33 | $312.95 | 2025-01-29 | $273.12 | +4.2% | 67% | B |
| Bernstein Autonomous Forensic Coverage | INITIATE | HOLD | $290.19 | — | 2025-01-17 | $278.81 | +2.0% | 61% | B |
| Barclays Capital Americas Research | DOWNGRADE | UNDERPERFORM | $250.36 | $270.27 | 2025-01-09 | $253.21 | -11.2% | 42% | D |
| UBS Investment Bank Institutional Desk | UPGRADE | BUY | $338.56 | $295.88 | 2024-12-18 | $247.51 | +14.9% | 72% | A |
| Citigroup Global Markets Sector Lead | TARGET REV | HOLD | $275.96 | $287.35 | 2024-12-04 | $264.59 | -4.3% | 48% | C |